L’Oreal Settles With FTC Over Gene-Related Anti-Aging Skin-Care Claims
This article was originally published in The Rose Sheet
Executive Summary
A proposed consent agreement between L’Oreal USA and the Federal Trade Commission bars the company from claiming that skin-care products from its Lancome and L’Oreal Paris brands target users’ genes to award anti-aging benefits. The settlement, which is subject to public comment and final FTC approval, follows a 2012 warning letter from FDA that cited some of the same marketing claims.